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predict cardiovascular disease (CVD) in a rural area in Northern Viet-
nam, using data on hypertension from the communities. Methods:
A cross-sectional survey was conducted including all residents in
selected communities, aged 34 to 65 years, during April to August
2012 in Thai Nguyen province. Data on age, sex, smoking status,
blood pressure, and blood tests (glucose, total cholesterol, low-
density lipoprotein cholesterol, high-density lipoprotein cholesterol)
were collected to identify the prevalence of high blood pressure and
to use as input variables for the models. We compared three models,
Asian, Chinese Multiple-provincial Cohort Study (CMCS), and Fra-
mingham, to estimate cardiovascular risk in the coming years in this
context and compare these models and outcomes. Results: The
prevalence of high blood pressure in these communities was lower
than reported nationally (12.3%). CVD risk differed greatly depending
on the model applied: approximately 21% of the subjects according
to the CMCS and Asian models, but 37% using the Framinghamee front matter Copyright & 2014, International S
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gen, Antonius Deusinglaan 1, Building 3214, Roomodel, had more than 10% risk for CVD. In the group without current
CVD, these numbers decreased to 9% using the CMCS and Asian
models but increased to 28% according to the Framingham model.
There were no signiﬁcant differences between the Asian and CMCS
models, but differences were highly signiﬁcant when comparing
Asian versus Framingham or CMCS versus Framingham model.
Conclusions: The Asian and CMCS models provided similar results
in predicting CVD risk in the Vietnamese population in Thai Nguyen.
The Framingham model provided vastly different results. The sug-
gestion may be that for the speciﬁc Vietnamese setting, the Asian
and CMCS models provide most valid and reliable results; however,
this has to be investigated in further analyses using real-life data for
potential conﬁrmation.
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The burden of cardiovascular disease (CVDs) is increasing
worldwide; they are a leading cause of death both globally
and in Asian countries [1–3]. Of all CVDs, ischemic heart disease
and cerebrovascular disease/stroke were the most common
causes of death in 1990 and 2010, respectively. The mortality
rate of both diseases has increased over the past two decades:
approximately 35% for ischemic heart disease and 26% for
stroke. In 2010, both diseases also belonged to the top ﬁve
causes of years of life lost [1]. Hypertensive heart disease
increased from 18.3% in 1990 to 14.2% in 2010 in the global
ranking of causes of death. In Vietnam, CVD was among the top
10 leading causes of death in 2006, 2007, and 2009 [4,5]. Around
32% of deaths from noncommunicable diseases in rural areas
are caused by CVDs [6,7].
To make the best use of limited resources, planning of health
care interventions is important. Predictive modeling of the risk ofCVD can render valuable information for planning these health
interventions.
The ﬁrst step in the prediction of the CVD risk is the selection
of the best-ﬁtting model for the Vietnamese population. Over the
last decade, several models have been developed and validated.
The ﬁrst well-known model was developed in the United States
using data from the Framingham study. This model, however,
might be less reliable in other populations and has overestimated
or underestimated the CVD risks in speciﬁc settings [8,9]. There-
fore, other models were developed, such as the Systematic
Coronary Risk Evaluation model in Europe [10], a risk model
based on QRESEARCH database in the United Kingdom [11], the
Prospective Cardiovascular Münster study in Germany [12], a risk
model assessing cardiovascular risk, using SIGN guidelines to
assign potential patients to preventive treatment in Scotland [13],
and a risk model based on database of CUORE Cohorts Project in
Italy [14]. In Asia, models to predict CVD risk have been devel-
oped in Thailand, China (Chinese Multiple-provincial Cohortociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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populations, a tool was developed on the basis of six cohorts in
this region (Asian model) [8,15–21]. Because all these models vary
in different aspects such as the time horizon used, characteristics
of study population included, input variables, and outcome, they
may all produce different results. In Vietnam, with its own
environment of biological, behavioral, and social characteristics,
there is not yet a speciﬁc model to predict CVD. The largest
survey on risk factors for CVD done in Vietnam applied the
Framingham model only [22]. Also, the Framingham model is
explicitly introduced on the Vietnam Heart Association Web site.
The aim of this study was to calculate the CVD risk using two
prediction models developed in Asia and to assess to what extent
these results coincide with CVD risks calculated using the long-
established Framingham model. In this way, we hope to identify
the most suitable model to predict future patterns of disease for
health planners in Vietnam.
The second step for modeling the CVD risk is information on
risk factors and demographic characteristics of the population. It
is well known that improved CVD management could be
approached through changing lifestyle. In addition, there are
concerns on the capacity of health services to adequately detect
risk factors such as hypertension. It is estimated that half of the
expected 25% hypertensive individuals in the population are not
aware of their hypertension [23]. Better CVD management is a
public health concern, and hypertension detection and treatment
are crucial elements in that management. There have been large
surveys on hypertension in Vietnam [22,23]. This report describes
a smaller but potentially more intensive study. A speciﬁc subaim
of our study was to collect complete and reliable data to assess
the prevalence of hypertension and distribution of risk factors in
four rural communities in a mountainous area in the North of
Vietnam, subsequently to be used as input variables for CVD
models.Methods
Models
As described above, several CVD prediction models are available
around the world. In this study, we selected two models devel-
oped in Asia because their target populations may share a similar
background of disease and risk factors for CVD to Vietnam. This
would avert the potential overestimation or underestimation that
may appear when the Framingham model or others developed
for Western countries are used. The Asian model was validated
on the basis of six cohorts in Asia and may be most representa-
tive for Asian countries. The CMCS model was developed on the
basis of cohorts in 11 provinces in China. We are interested in
this model as well because Vietnamese share a background of
mortality patterns with the Chinese: The share of CVD was 40%
in Vietnam and 38% in China among deaths due to noncommu-
nicable disease, which account for 80% of all deaths in China and
75% of all deaths in Vietnam. Age-standardized death rate per
100,000 due to CVD and diabetes was similar in China and
Vietnam (males: 311.5 and 381.5 in China and Vietnam; females:
259.6 and 298.2 in China and Vietnam, respectively). The inci-
dence of high blood pressure (BP) in 2010 was 38.2% in China and
33% in Vietnam. Patterns of obesity or overweight may, however,
be different [24,25].
We also applied the Framingham model, which is widely used
and also—as mentioned earlier—is presented on the Vietnam
Heart Association Web site. This tool was developed from a
cohort of Americans who were free of coronary heart disease
and diabetes to predict the 10-year risk of myocardial infarction
and coronary heart death.Risk factors included in the models differ to some extent.
Information on sex, age, and smoking status is, however,
included in all the three models. Furthermore, the CMCS model
includes information on diabetes, stage of hypertension, total
cholesterol, and high-density lipoprotein cholesterol. In the Asian
model, systolic blood pressure (SBP) and total cholesterol are
used as input variables. In the Framingham model, the following
variables are used: total cholesterol, high-density lipoprotein
cholesterol, and SBP.
We calculated the CVD risk of each individual using the
equations of CMCS and Asian models, which consider the above
input variables, and their own mean survival rate, regression
coefﬁcients, and mean values of the risk factors in the CMCS or
Asian model. In the Framingham model, we calculated the point
score of each input variable and translated point scores into risk
levels, guided by the Framingham Heart Study. The CMCS, Asian,
and Framingham models have been described in detail [8,26,27].
The CVD risk was assessed using all the three models for two
scenarios. The base case excluded all cases with current CVD,
whereas in the sensitivity analysis, all cases, both with and
without current CVD, were included.
Study Population and Study Design
A cross-sectional study was conducted from April to August 2012
in Thai Nguyen, a mountainous province in the north of Vietnam.
Four districts, all around 40 km from Thai Nguyen city, were
purposively selected; we then chose one commune in the middle
of each district. Within each commune, all villages having an
active health care worker were listed. From this list, we selected
randomly enough villages to cover 45% to 50% of the total
population in that commune.
All residents from 35 to 64 years old in each village were
invited to participate in the study. Exclusion criteria, based on
self-reported medical history or alcohol consumption, were
current pregnancy, mental health disease, heavy alcohol con-
sumption (often drunk), cancer, AIDS, current treatment of
hypertension or diabetes, or a medical history of myocardial
infarction, stroke, heart failure, or kidney failure.
Medical students and village health workers, who were
trained on BP measurement and on using the study question-
naires, collected data at a village center or in the household. Data
were collected on demographic characteristics (sex, age, ethnic-
ity, education, occupation, and residence) and risk factors for
CVD (smoking, alcohol consumption), and BP was measured. All
subjects who had SBP of 140 mm Hg or more and/or diastolic
blood pressure (DBP) of 90 mm Hg or more were invited to visit
the community health center for a second BP measurement 5 to 7
days after the ﬁrst measurement. All subjects who still had SBP of
140 mm Hg or more and/or DBP of 90 mm Hg or more on the
second day were medically examined, an electrocardiogram was
done (ECG), and blood samples were collected. These people were
advised to manage high BP at their community health center or
were referred to a higher level for further investigation. All
subjects who had SBP of less than 140 mm Hg and/or DBP of less
than 90 mm Hg were advised to check their BP regularly.
Measurement and Classiﬁcation
BP measurement: Participants were advised to avoid drinking
alcohol the day before the visit, and to stop smoking cigarette,
drinking coffee/tea, and taking exercise for at least 30 minutes
before their BP measurement. Automatic sphygmomanometers
(OMRON, model HEM-7200-C1, Omron Healthcare, Kyoto, Japan)
with an appropriate sized cuff were used. BP was measured twice
for everyone, with participants in a sitting position after at least
10 minutes of rest. A third measurement was performed if the
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or DBP. Average SBP and/or DBP of the ﬁrst and second or second
and third measurements was used for analysis [28,29]. Hyper-
tension was deﬁned as an SBP value of 140 mm Hg or more and/
or a DBP value of 90 mm Hg or more on the second visit. It has
been recommended that in a setting of scarce resources, the
value of BP at the second visit would be suitable for a reliable
measurement of the real prevalence of hypertension in the
community [30]. Hypertension was classiﬁed according to the
Seventh Joint National Committee on Hypertension Classiﬁcation
[31].
Occupations were assigned to one of seven categories: farmer,
worker, businessperson, wage earner, housewife, government
ofﬁcer, and other.
At the second visit, patients were examined by medical
doctors from Thai Nguyen University of Medicine and Pharmacy.
For this study, we deﬁned coronary heart disease (including
angina, left ventricular hypertrophy, myocardial infarction, or
heart failure) by medical history, physical examination, and
result of ECG. Blood tests (glucose, total cholesterol, low-density
lipoprotein cholesterol, high-density lipoprotein cholesterol)
were performed by a team from Thai Nguyen General Hospital.
Diabetes was deﬁned as fasting blood glucose level of 7 mmol/L
or more [32]. Subjects who smoked cigarettes or pipe during the
last month were deﬁned as current smokers.Statistical Analysis
Chi-square, student’s t test, or Mann-Whitney test were used to
compare differences in biological factors among different visits,
different groups, and the distribution of CVD in different models.
Chi-square testing was used to compare model differences. On
the basis of the Guideline for Assessment and Management of
Cardiovascular Risk, we used 10% as the cutoff point for CVD
risks over a 10-year period. In particular, it is stated that with a
10-year risk of CVD of more than 10%, subjects need to bePresent in communities during screening for
hypertension: 4386 subjects selected
Attended the screening: 
3779 subjects (3779*100/4386 = 86.5%)
Hypertension during the first measurement: 776
subjects (776*100/3779=20.5%)
Hypertension during the second measurement: 4
subjects (466*100/766=60.8%)
Blood samples: 442 subjects (entering the model
Fig. 1 – Flowchart of selecting the ﬁnal sample. Notes. We selected
We required blood samples from all cases to have values for almonitored regularly [33]. All statistical analysis was performed
using STATA 10.
Ethical Issues
The research proposal was approved by the Institutional Review
Board in biomedical research in the Institute of Social and
Medical Studies in Vietnam. The study was explained to all those
invited to join, and all subjects signed a consent form before
participating in the study. All participants had the right to
withdraw from the study at any time. Patients who were found
to have high BP were advised to manage it at their community
health station or were referred to a higher level for specialist
examination if needed. Subjects without high BP were advised to
monitor their BP regularly.Results
Study Population Characteristics
The 3779 subjects who participated in the study comprised 86.5%
of all those who were invited (Fig. 1). They included 43.3% men,
and 84% were ethnically Kinh (the majority ethnic group in
Vietnam). The most common occupation (72.5%) was farmer,
and the mean age was 47.4  8 years.
In this study, hypertension prevalence is a key factor and an
important input variable. We therefore ﬁrst present the data on
hypertension prevalence, followed by the CVD model results.
Prevalence of Hypertension
The distribution of BP among 3779 subjects at the ﬁrst visit is
presented in Table 1. Among this study population, 776 subjects
(20.5%) had an SBP value of 140mmHg ormore and/or a DBP value of
90mmHg ormore during the ﬁrst visit. The prevalence of elevated BP
was greater among men than among women (28.3% vs. 14.6%, P o
0.001) and increased with age (10.5%, 23.9%, and 33.4% in 35–44-, 45– 
66 
s)
589 subjects declined to 
participate in the screening
589 subjects refused to 
participate 
3003 subjects without 
hypertension in the first 
measurement
10 subjects not followed
up and 300 subjects 
without hypertension in the 
second measurement
24 subjects did not provide 
blood samples
all subjects with hypertension in the second measurement.
l variables to be included in the analysis with three models.
Table 1 – Prevalence of blood pressure classiﬁcation in study population, stratiﬁed by sex and age group (%) at
ﬁrst visit (n ¼ 3779).
Study population Normal Prehypertension Stage 1 Stage 2 P
Men (y)
35–44 30.6 52.9 13.2 3.3 0.000
45–54 22.0 45.2 21.8 11.0
55–64 19.1 38.0 26.0 16.9
Women (y)
35–44 64.5 29.6 4.3 1.5 0.000
45–54 46.7 36.0 12.6 4.7
55–64 36.5 37.3 18.1 8.1
Total
Men 24.9 46.8 19.2 9.1 0.000
Women 51.7 33.7 10.5 4.2
Both sexes 40.1 39.4 14.2 6.3
Notes. The blood pressure level was classiﬁed according to JNC 7: Normal: SBP/DBP o 120/80 mm Hg; prehypertension: SBP/DBP is 120–139/80–
89 mm Hg; stage 1: SBP/DBP is 140–159/90–99 mm Hg; stage 2: SBP/DBP Z160/100 mm Hg; men vs. women: P ¼ 0.000. DBP, diastolic blood
pressure; SBP, systolic blood pressure.
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the second visit, at which 766 subjects appeared, 466 subjects (60.8%)
still had a high BP. Using the BP values of this second visit, the overall
prevalence of hypertension in the total population (3779 subjects) was
12.3%, including 16% of men and 9.6% of women (P o 0.001).
Both the median and mean value of the SBP and DBP were lower
at the second visit compared withmeasurements during the ﬁrst visit
(mean 151.3 and 147.7mm Hg; median 148 and 145mm Hg at the
ﬁrst and second visits, respectively, Po 0.001). The range of BP at the
second visit, however, was greater than at the ﬁrst visit. Biological
factors among hypertensive subjects (at second measurement) are
presented in Table 2. Because blood tests data of 24 subjects wereTable 2 – Characteristics of hypertensive patients (n ¼ 44
Characteristics Model used Men
Age (y), mean  SD CMCS, Asian, Framingham 52
Smoking (%) CMCS, Asian, Framingham
Diabetes (cases) CMCS
SBP (mm Hg), mean  SD Asian 15
Stage of hypertension (cases) CMCS, Framingham
SBP 140–159 mm
Hg or DBP 90–99 mmHg
1
SBP Z 160 mm Hg or DBP
Z 100 mm Hg
1
TC (mmol/L), mean  SD Asian 5.0
TC (cases) CMCS, Framingham (mg/dl)
o160
160–199
200–239
240–279
Z280
HDL-C (cases) CMCS, Framingham (mg/dl)
o35
35–44
45–49
50–59
Z60
CMCS, Chinese Multiple-provincial Cohort Study; DBP, diastolic blood pres
pressure; TC, total cholesterol.missing, data on only 442 subjects are presented. Age, fasting glucose,
and SBP were comparable between men and women (P4 0.05). Total
cholesterol and low-density lipoprotein cholesterol levels were lower
in men (P o 0.05 and P o 0.01, respectively), whereas high-density
lipoprotein cholesterol level was higher in men (P o 0.05).
Comparison of Future Patterns of CVD Using CMCS, Asian,
and Framingham Models
Risks of coronary heart disease were estimated using three
models: the CMCS, Asian, and Framingham models. In the base
case, we excluded cases with a diagnosis of CVD at the time of2 subjects).
(n ¼ 244) Women (n ¼ 198) Both
sexes
P
.1  7.8 53  7.3 52  7.6 0.249
38.93 0 21.49 0.000
3 2 5 0.828
9  15.7 158  14.7 158 15 0.505
32 116 248 0.344
12 82 194
3  1.51 5.22  1.17 5.11  1.37 0.015
59 36 95 0.127
93 64 157 0.206
58 60 118 0.123
23 28 51 0.123
11 10 21 0.790
21 22 43 0.377
63 58 121 0.415
45 35 80 0.835
57 53 110 0.410
58 30 88 0.024
sure; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood
Table 3 – Prevalence of risk of cardiovascular events according to different models in rural mountainous
Vietnam, stratiﬁed by sex and age group (excluding cases having CVD) (%).
Study population CMCS Asian Framingham
o10% Z10% P o10% Z10% P o10% Z10% P
Age group (y) 0.000 0.000 0.000
35–44 100 100 96.67 3.33
45–54 98.77 1.23 93.87 6.13 80.37 19.63
55–64 73.62 26.38 84.66 15.34 53.99 46.01
Sexes 0.000 0.000 0.000
Men (n ¼ 203) 100 84.24 15.76 46.8 53.2
Women (n ¼183) 75.41 24.59 98.36 1.64 99.45 0.55
Both sexes (n ¼ 386) 88.34 11.66 90.93 9.07 71.76 28.24
P 0.000
Notes. CMCS model vs. Asian model: P ¼ 0.238; CMCS model vs. Framingham model: P ¼ 0.000; Asian model vs. Framingham model: P ¼ 0.000.
CMCS, Chinese Multiple-provincial Cohort Study; CVD, cardiovascular disease.
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prevalence of “more than 10% CVD risk” when the Framingham
model was applied was 28.24%, higher than that for the CMCS
(11.7%) and Asian (9.1%) models. For women, 24.6% were at more
than 10% CVD risk according to the CMCS model compared with
only 1.6% and 0.5% in the Asian and Framingham models, respec-
tively. In the age group 55 to 64 years, the prevalence of more than
10% CVD risk was highest (46%) using the Framingham model and
lowest (15.3%) with the Asian model. The differences in the results
between the CMCS model versus the Framingham model and the
Asian model versus the Framinghammodel were highly signiﬁcant
(P o 0.001). There were, however, no signiﬁcant differences
between results from the CMCS and the Asian (P 4 0.05) models.
In the sensitivity analysis, we included cases with a diagnosis
of CVD at the examination at the second visit in each of the three
models, and placed those cases in groups with more than 10%
CVD risk (Table 4). The prevalence of more than 10% CVD risk was
highest in the Framingham model (22.2%, 20.6%, and 37.3% in
CMCS, Asian, and Framingham models, respectively; P o 0.01).
The prevalence more than 10% CVD risk in women was similar in
the Asian and Framingham models (8% and 9% in Framingham
and Asian models, respectively), but it was three times higher
when the CMCS model was used (30.3%). In contrast, theTable 4 – Prevalence of risk of cardiovascular events acc
Vietnam, stratiﬁed by sex and age group (including case
Study population CMCS model
o10% Z10% P o1
Age group (y) 0.000
35–44 88.24 11.76 88.
45–54 85.19 14.81 80.
55–64 64.86 35.14 74.
Sexes 0.001
Men (n ¼ 244) 83.2 16.8 70.
Women (n ¼ 198) 69.7 30.3 90.
Both sexes (n ¼ 442) 77.85 22.15 79.
P
Notes. CMCS model vs. Asian model: P ¼ 0.415; CMCS model vs. Framingh
men vs. women: P ¼ 0.000.
CMCS, Chinese Multiple-provincial Cohort Study; CVD, cardiovascular diprevalence of more than 10% CVD risk in men was lowest using
the CMCS model (16.8%) and highest using the Framingham
model (61.07%). CVD risk increased with age in all models (P o
0.001). In the 55- to 64-year-old group, the prevalence of more
than 10% CVD risk was 25.4%, 35.1%, and 52.4% in the Asian,
CMCS, and Framingham models, respectively.Discussion
Hypertension is a key risk factor for CVD, which is a leading cause
of death in Asia and in Vietnam. Prediction of CVD risk by using the
most appropriate model for Vietnamese population would support
the management of CVD in curative and preventive health care. In
this study, we predicted CVD risk among hypertensive patients by
using and comparing three established prediction models.
BP measurements were taken during the ﬁrst visit to the
community and for those with high BP, again on the second visit
a few days later [30]. The prevalence of high BP decreased from
20.5% at the ﬁrst visit to 12.3% at the second visit, which is low
compared with results from previously reported studies in
Vietnam (25.1% and 26.4%) [22,23]. The difference could be
explained by differences in study methods and geographicalording to different models in rural mountainous
s having CVD) (%).
Asian model Framingham model
0% Z10% P o10% Z10% P
0.046 0.000
24 11.76 85.29 14.71
95 19.05 69.31 30.69
59 25.41 47.57 52.43
0.000 0.000
08 29.92 38.93 61.07
91 9.09 91.92 8.08
41 20.59 62.67 37.33
0.000
am model: P ¼ 0.000; Asian model vs. Framingham model: P ¼ 0.000;
sease.
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population in both urban and rural areas; blood tests were
conducted in 20% of the urban study population, and BP was
measured during one visit. Our study was conducted in a rural
mountainous area, measuring all the village population from 34
to 65 years old, and the BP was measured on two separate
occasions in all subjects with high BP at the ﬁrst visit. The
prevalence of high BP in our study was within the range reported
in other low- and middle-income countries in Asia (15%, 29%, and
44.6% in Cambodia, Malaysia, and Mongolia, respectively) [34].
Again, these studies measured the BP only at a single visit, which
may lead to overestimates of high BP prevalence. This ﬁnding
suggests that researchers must be careful in identifying the
burden of disease in a speciﬁc setting and group; accurate data
are needed for planning and allocation of scarce resources.
CVD risk differed largely depending on the model applied:
approximately 9% of the subjects according to the CMCS and
Asian models, but using the Framingham model, 28% had a more
than 10% risk for CVD. The percentage of subjects having a more
than 10% CVD risk in our study (9%–28%) was lower than that
reported in previous studies in Vietnam (40.9%), possibly because
they used the Framingham model only. It was high compared
with the numbers reported from other Asian countries in the age
group 40 to 64 years (3%, 5.6%, 3.9%, and 11.4% in Cambodia,
Malaysia, China, and Mongolia, respectively) [22,34,35]. This
comparison, however, is of only limited validity because different
methods were used to estimate CVD risk in these studies. Studies
in other Asia countries used WHO/ISH risk prediction charts and
were aware of the potential underestimation of CVD risk [34]. The
earlier study in Vietnam may have overestimated the CVD risk
also because it measured BP only at one visit and did blood tests
only on the urban sample. These limitations may present a
challenge for both curative and preventive care in CVD manage-
ment based on such data.
In our study, inclusion or exclusion of current CVD was found
to affect the predicted future pattern of CVD risk differently in
each model. The results from the CMCS and Asian models were
comparable, but results from the Framingham model differed
signiﬁcantly. None of these models have yet been validated in
Vietnam. Previous studies have suggested that applying the
Framingham model in Europe and Asia resulted in overestimates
of the burden of disease, where there were lower rates of CVD
[8,13,36–39]. The differences when using the three models can be
explained by the different components in each model, such as
characteristics of study population, input variables, outcome
variables, time horizon, and values in each equation. The Asian
model considers the mean age, SBP, total cholesterol, and
smoker/nonsmoker; outcome is deﬁned as cardiovascular death,
nonfatal myocardial infarction, and nonfatal cerebrovascular
events in the following 8 years. The CMCS equation uses a
subgroup of risk factors, no mean values as in the Asian
equation, and outcome is deﬁned as coronary death and myo-
cardial infarction in the coming 10 years.
Vietnam should of course ideally have its own cohort to feed
these models to predict CVD risk and validate models for the
national setting. Even building an own Vietnamese model could
be considered, may be an adaptation of one of these existing
models. Because of the long time needed for that, and because of
resource constraints, however, it may initially be very legitimate
to use a model from countries with similar contextual factors,
such as the CMCS model or the Asian model, to predict patterns
of CVD risk in the coming years as a basis for planning and
management of services in Vietnam.
There are limitations to our study. First, we could not conﬁrm
high BP using ambulatory BP monitoring. Measurements taken at
two visits, however, are considered acceptable for low-resource
settings [30]. Second, we identiﬁed cases with current CVD on thebasis of only medical history, clinical examination, and ECG, so
we may have lost cases with CVD without clinical symptoms and
signs in ECG. Third, the CMCS, Asian, and Framingham original
models can be applied to general populations. In this study, we
tested them only in hypertensive patients, which reﬂect a limi-
tation of our study. Notably, this may reduce the generalizability
of our ﬁndings. Finally, availability of real data at the current stage
does not allow us to demonstrate the appropriateness of one
prediction model over the other; that is, we cannot infer which
model(s) is (are) best for the speciﬁc Vietnamese population. The
suggestion certainly is that the CMCS and Asian models could
provide most reliable and valid results, but further research in
practice has to substantiate this hypothesis.
In conclusion, the prevalence of high BP in a rural mountain-
ous area of Vietnam was found to be lower than previously
reported for Vietnam, but still sufﬁcient to warrant attention
from health services. Our results demonstrate that the Asian and
CMCS models provided similar outcomes in predicting CVD risk
in the Vietnamese population. Prediction of risk using the Asian
and CMCS models than the Framingham model could be sug-
gested to be more appropriate for the Vietnamese context
because they are from the same region. The Framingham model
also provides vastly different results. The suggestion that for the
speciﬁc Vietnamese setting, the Asian and CMCS models provide
most valid and reliable results should however be investigated in
further analyses using real-life data for potential conﬁrmation.
The results of this study are useful to health planners and will
provide a basis for a further study on cost-effectiveness modeling
of CVD management.Acknowledgments
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